Authors: Canton, T Bohme, GA Boireau, A Bordier, F Mignani, S Jimonet, P Jahn, G Alavijeh, M Stygall, J Roberts, S Brealey, C Vuilhorgne, M Debono, MW Le Guern, S Laville, M Briet, D Roux, M Stutzmann, JM Pratt, J

Citation: T. Canton et al., RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: Synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis, J PHARM EXP, 299(1), 2001, pp. 314-322

Authors: Boireau, A Dubedat, P Bordier, F Imperato, A Moussaoui, S

Citation: A. Boireau et al., The protective effect of riluzole in the MPTP model of Parkinson's diseasein mice is not due to a decrease in MPP+ accumulation, NEUROPHARM, 39(6), 2000, pp. 1016-1020

Authors: Boireau, A Monterrat, C Bordier, F Meunier, M Imperato, A

Citation: A. Boireau et al., Effects of RPR 118723, a novel antagonist at the glycine site of the NMDA receptor, in vitro, EUR J PHARM, 401(2), 2000, pp. 131-135